je.st
news
Tag: candidates
Election 2013: Meet the Candidates; Steven Morabito, candidate for Councillor-at-Large
2013-06-01 00:00:44| Grocery - Topix.net
Revere resident Steven Morabito is once again running for city council. Last election he won on Election Day, forcing out incumbent John Correggio for an at-large seat on the council, but after a recount he lost by a few votes.
Tags: meet
candidate
election
candidates
GOP Candidates Nominated
2013-05-23 05:14:49| Paper - Topix.net
The G.O.P. slate of candidates for statewide office is set for November. Delegates attending the Republican Party of Virginia convention in Richmond Saturday chose Chesapeake minister E.W. Jackson for lieutenant governor from among seven candidates.
Tags: candidates
nominated
gop
gop candidates
VA's GOP Candidates Stop in Albemarle on Fly-Around Tour
2013-05-22 01:31:25| Chemicals - Topix.net
The republican nominees for statewide office are making their way around the commonwealth this week.
Tags: stop
tour
candidates
vas
Quest Diagnostics Will Not Automatically Disqualify Job Candidates With Arrest History
2013-05-09 22:45:43| Biotech - Topix.net
New York State has reached a settlement with Quest Diagnostics, one of the world's largest providers of medical diagnostic testing, information and services, to ensure that applicants for employment are not automatically disqualified based on prior arrests or criminal convictions and without considering mitigating factors.
Tags: history
job
automatically
quest
Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C
2013-04-22 13:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK) today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibbs investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus (HCV) infection, genotype 1. Language: English Contact HTML: MerckMedia:Caroline Lappetito, (267) 305-7639orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: c
agreement
trial
combination
Sites : [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] next »